---
category: news
title: "Northpond, 5AM Ventures lead $45M funding for CAMP4â€™s trek to new RNA therapies"
excerpt: "CAMP4 Therapeutics is developing a new kind of RNA therapy that treats disease by upregulating gene expression. The startup has raised $45 million as CEO Josh Mandel-Brehm steers toward clinical trials expected to begin next year in liver and brain diseases."
publishedDateTime: 2021-06-16T14:37:00Z
originalUrl: "https://medcitynews.com/2021/06/northpond-5am-ventures-lead-45m-funding-for-camp4s-trek-to-new-rna-therapies/"
webUrl: "https://medcitynews.com/2021/06/northpond-5am-ventures-lead-45m-funding-for-camp4s-trek-to-new-rna-therapies/"
type: article
quality: 0
heat: 0
published: false

provider:
  name: MedCity News
  domain: medcitynews.com

topics:
  - AI in Healthcare
  - AI

secured: "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;eHi5CZO6cbhrelCS4Kk2pw=="
---

